Christine E. Brown Department of Hematology & Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory City of Hope Beckman Research Institute and Medical Center Biography Publications Institution JoVE Articles Christine E. Brown has not added a biography. If you are Christine E. Brown and would like to personalize this page please email our Author Liaison for assistance. Publications Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy Against Glioblastoma Molecular Therapy : the Journal of the American Society of Gene Therapy. 01, 2018 | Pubmed ID: 29103912 Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 Breast Cancer Metastasis to the Brain Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2018 | Pubmed ID: 29061641 Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model Stem Cells Translational Medicine. Jun, 2017 | Pubmed ID: 28481046 Regression of Glioblastoma After Chimeric Antigen Receptor T-Cell Therapy The New England Journal of Medicine. 12, 2016 | Pubmed ID: 28029927 Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2015 | Pubmed ID: 26059190 Stem-like Tumor-initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-zetakine-redirected T Cells Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2012 | Pubmed ID: 22407828 Tumor-derived Chemokine MCP-1/CCL2 is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells Journal of Immunology (Baltimore, Md. : 1950). Sep, 2007 | Pubmed ID: 17709550 In Vitro del tumore delle cellule Rechallenge per valutazione predittiva della funzione antitumorale chimerico antigene recettore delle cellule T Dongrui Wang1,2, Renate Starr1, Darya Alizadeh1, Xin Yang1, Stephen J. Forman*1, Christine E. Brown*1 1Department of Hematology & Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory, City of Hope Beckman Research Institute and Medical Center, 2Irell and Manella Graduate School of Biological Sciences, City of Hope Beckman Research Institute and Medical Center JoVE 59275 Cancer Research
In Vitro del tumore delle cellule Rechallenge per valutazione predittiva della funzione antitumorale chimerico antigene recettore delle cellule T Dongrui Wang1,2, Renate Starr1, Darya Alizadeh1, Xin Yang1, Stephen J. Forman*1, Christine E. Brown*1 1Department of Hematology & Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory, City of Hope Beckman Research Institute and Medical Center, 2Irell and Manella Graduate School of Biological Sciences, City of Hope Beckman Research Institute and Medical Center JoVE 59275 Cancer Research
